(Total Views: 78)
Posted On: 06/28/2023 8:35:45 AM
Post# of 89450

$CLRB News Article - Cellectar Biosciences Highlights Promising Interim Data from Its Ongoing Study of Iopofosine I 131 in Multiple Myeloma in an Oral Presentation at the SNMMI Annual Meeting https://marketwirenews.com/news-releases/cell...19027.html


My Twitter: WhyteStocks